TSBX
Turnstone Biologics Corp.
0.35
undefined x undefined
undefined x undefined
bid
ask
+
0.00
0.00%
04:00 PM
timesize
| Ytd | ||
| 1y |
0.35
day range
0.35
0.40
52 week range
5.75
| Open | 0.35 | Prev Close | 0.35 | Low | 0.35 | High | 0.35 | Mkt Cap | 10.46M |
| Vol | 283.77K | Avg Vol | 273.99K | EPS | -2.28 | P/E | N/A | Forward P/E | -0.19 |
| Beta | N/A | Short Ratio | 1.03 | Inst. Own | 60.24% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 0.50 | 200-d Avg | 1.76 | 1yr Est | 2.38 |
| Income Statement | |||
| Operating Expenses | 5.56M | ||
| Research and Development Expense | 171.00K | ||
| Selling, General and Administrative Expense | 5.39M | ||
| Operating Income | -5.56M | ||
| Income Tax Expense | 12.00K | ||
| Net Income | -5.49M | ||
| Net Income Common Stock | -5.49M | ||
| Net Income Common Stock (USD) | -5.49M | ||
| Consolidated Income | -5.49M | ||
| Earnings per Basic Share | -0.24 | ||
| Earnings per Basic Share (USD) | -0.24 | ||
| Earnings per Diluted Share | -0.24 | ||
| Earning Before Interest & Taxes (EBIT) | -5.48M | ||
| Earning Before Interest & Taxes (USD) | -5.48M | ||
| Weighted Average Shares | 23.14M | ||
| Weighted Average Shares Diluted | 23.14M | ||
| Balance Sheet | |||
| Cash and Equivalents | 18.59M | ||
| Cash and Equivalents (USD) | 18.59M | ||
| Current Assets | 21.11M | ||
| Property, Plant & Equipment Net | 313.00K | ||
| Total Assets | 21.11M | ||
| Debt Current | 411.00K | ||
| Total Debt | 411.00K | ||
| Current Liabilities | 6.35M | ||
| Total Liabilities | 6.35M | ||
| Accumulated Retained Earnings (Deficit) | -264.89M | ||
| Accumulated Other Comprehensive Income | -202.00K | ||
| Shareholders Equity | 14.76M | ||
| Shareholders Equity (USD) | 14.76M | ||
| Total Debt (USD) | 411.00K | ||
| Trade and Non-Trade Payables | 2.69M | ||
| Cash Flow | |||
| Net Cash Flow / Change in Cash & Cash Equivalents | -3.37M | ||
| Capital Expenditure | 935.00K | ||
| Net Cash Flow from Investing | 935.00K | ||
| Net Cash Flow from Operations | -4.30M | ||
| Share Based Compensation | 268.00K | ||